Skip to main content
Category

Commentary

Imaging Utilization Slows

By Commentary No Comments

Imaging has been a poster boy for alleged excessive and inappropriate utilization, resulting in higher than necessary spending. A study reported in Health Affairs finds that, for Medicare and commercial insurers, imaging growth has slowed, and the researchers explore why this may be so.

Read More

Engagement in Health

By Commentary No Comments

Patient and family engagement in health and managing health care is a necessary condition to seeing real improvement in our health system. A report from the Agency for Healthcare Research and Quality looks at various techniques for creating such engagement in regard to hospital care.

Read More

2012 Potpourri XXIII

By Commentary No Comments

At the height of the summer, with dryness across the land, there is no drought of information in our Potpourri, this week including use of an interactive health record to increase preventive care, Medicare and Medicaid geographical variation, shared decision-making, readmissions for heart attacks and Japan’s all-payer rate setting system.

Read More

Patient Satisfaction

By Commentary No Comments

Patient satisfaction and patient-centered care are two health care movements which are being incented and rewarded by various government and private payer programs, but a Perspective in the Journal of the American Medical Association points out that these concepts may not lead to the most desirable outcomes.

Read More

2012 Potpourri XXII

By Commentary No Comments

Our Potpourri finally returns, including items on duplicate payments in federal health programs, EHR use and malpractice claims, venture capital statistics, consumer use of online self-service applications, and a new statistical method for predictive modeling.

Read More

Rand on CDHP

By Commentary No Comments

No matter how controversial they may be, consumer-directed health plans with their higher cost-sharing continue to spread rapidly. A Rand Corporation brief examines the evidence on the effect of these plans on the cost and use of health care.

Read More

IMS Drug Report

By Commentary No Comments

IMS has a tremendous amount of information on prescription drug use and their reports are always worth paying attention to. The latest provides their outlook through 2016, finding steady increases in overall global spending, with less on brand names and more on generic.

Read More